KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,133,000 | +24.6% | 16,650 | 0.0% | 0.02% | +21.4% |
| Q2 2017 | $1,712,000 | -30.9% | 16,650 | -47.4% | 0.01% | -39.1% |
| Q1 2017 | $2,477,000 | +5.9% | 31,650 | -37.4% | 0.02% | -8.0% |
| Q4 2016 | $2,338,000 | -53.6% | 50,550 | -43.8% | 0.02% | -55.4% |
| Q3 2016 | $5,035,000 | -30.9% | 89,950 | -37.1% | 0.06% | -32.5% |
| Q2 2016 | $7,289,000 | +590.9% | 142,950 | +499.4% | 0.08% | +591.7% |
| Q1 2016 | $1,055,000 | -24.3% | 23,850 | +7.2% | 0.01% | -25.0% |
| Q4 2015 | $1,393,000 | +15.6% | 22,250 | +2.8% | 0.02% | +6.7% |
| Q3 2015 | $1,205,000 | -4.5% | 21,650 | +4.6% | 0.02% | 0.0% |
| Q2 2015 | $1,262,000 | +21.6% | 20,700 | +15.0% | 0.02% | +15.4% |
| Q1 2015 | $1,038,000 | – | 18,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |